The U.S. Federal Trade Commission (FTC) has mandated that Aurobindo Pharma must sell off four specific drug products. This action is a condition for Aurobindo Pharma to finalize its acquisition of Lannett Company Inc., ensuring no anti-competitive issues arise from the deal.
Source link
Trending
- Apple price hikes may flatten India iPhone growth; analysts cut forecast from double-digit to flat
- Employers to college students: Skip the perfect GPA and go get a summer job
- Pete Hegseth accuses Nato countries of ‘free riding’ in combative address | Pete Hegseth
- US Air Force awards first CCA production contracts to General Atomics, Anduril
- Revolutionizing Highways: NHAI’s AI Tool ‘Margsarthi’ Detects Project Discrepancies | India News
- Palisades Fire suspect driven by societal revenge, expert testifies
- How to check CA Results May 2026, Pass percentage, Topper List Direct Link at icai.org, icai.nic.in
- Jared Leto’s unreal Skeletor transformation for ‘Masters of the Universe’ only took ’15 minutes’ (interview)
